TPM Navigation

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to TPM Solicitors & Consultants of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of TPM or any of its members to solicit any work through this website.

Final finding issued recommending anti-dumping duties on imports ‘2,2,4-Trimethyl-1,2Dihydroquinoline’ (TDQ) originating in or exported from China PR (19.03.2026)

Product description – The product under consideration is ‘2,2,4-Trimethyl-1,2Dihydroquinoline’ or also known as ‘TDQ’.

HS Codes – The product under consideration is classified under Chapter 38, Heading 3812 under the HS code 3812 31 00. The product under consideration is also imported under the HS codes, 3812 10 00, 3812 20 90, 3812 39 10 and 3812 39 90.

Countries involved – China PR

Applicant – NOCIL Limited

Period of investigation – 1st April 2023 to 30th June 2024

Injury period – 1st April 2020 to 31st March 2021, 1st April 2021 to 31st March 2022, 1st April 2022 to 31st March 2023 and the period of investigation.

Margins and recommended duties –

CountryProducerDumping margin (%)Injury margin (%)Duty (USD/MT)
China PRSennics Co., Ltd. Shandong40-5010-20440
China PRAll other producers/exporters50-6020-30549

Key findings –

  • Apart from the applicant, there is one other producer of the subject goods in India, viz., Lanxess India Private Limited.
  • NOCIL Limited is an eligible domestic industry within the meaning of Rules and satisfies the criteria of standing,
  • China PR is presumed as a non-market economy country since none of the producers/exporters from China PR have provided sufficient evidence to rebut this presumption as mentioned in para 8 of Annexure – I of the Rules.
  • The Authority has calculated normal value based on any other reasonable basis. The Authority has considered price payable in India calculated as per cost of production in India, duly adjusted for selling, general & administrative expenses and reasonable profits.
  • The imports from the subject country have increased till 2022-23 and thereafter declined in the period of investigation in both absolute and relative terms. Imports in POI were, however, higher than base year.
  • While the raw material prices increased over the injury period from the base year, the import prices have declined and have not moved in line with the raw material prices.
  • The subject imports are undercutting the prices of the domestic industry, and the price undercutting is positive and significant, and price has remained below the cost of sales of the domestic industry in 2022-23 and the period of investigation.
  • The prices of the domestic industry were both suppressed and depressed in the period of investigation.
  • The production, domestic sales and capacity utilization of the domestic industry declined in 2022-23 and thereafter increased in the period of investigation. The domestic industry has sold at losses to increase its sales.
  • The market share of the domestic industry declined in 2021-22 compared to 2020-21 but increased marginally thereafter.
  • The volume parameters have shown improvement in the period of investigation as the domestic industry sacrificed on its profitability parameters to keep imports in check.
  • Profitability, cash profit and the return on capital employed declined in 2022-23 and turned negative in the period of investigation.
  • The investigation did not show any other factor other than dumping from the subject country which could have caused injury to the domestic industry.
  • The impact of anti-dumping duty is negligible.
  • There is no demand and supply gap in the country. The capacity with the Indian industry is sufficient to cater the entire demand,
  • The imposition of duties will not be against public interest.

Stay Updated

Subscribe for latest insights, updates, and exclusive offers